Study Objective: This is a Phase 1 trial to investigate the safety and efficacy of the investigational drug, DCC-2618, administered orally (PO), in adult patients with advanced malignancies.
Sponsor: Deciphera Pharmaceuticals LLC
Trial Contact Information: Divya Sakamuri; 1-713-745-3296; [email protected] or Filip Janku; 713-563-1930; [email protected]
Requested Patient Involvement: ECD patients 18 years or older.
Known Centers Accepting ECD patients in the trial: MD Anderson, Houston, TX
ClinicalTrials.gov Identifier: NCT02571036
